Compare CBU & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBU | ITGR |
|---|---|---|
| Founded | 1866 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 1994 | 2000 |
| Metric | CBU | ITGR |
|---|---|---|
| Price | $57.12 | $84.68 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $66.67 | ★ $91.14 |
| AVG Volume (30 Days) | 196.9K | ★ 944.5K |
| Earning Date | 04-27-2026 | 05-18-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ 15.41 | N/A |
| EPS | ★ 3.97 | 2.89 |
| Revenue | $818,007,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | $13.46 | $1.69 |
| Revenue Next Year | $7.66 | $6.53 |
| P/E Ratio | ★ $14.51 | $29.58 |
| Revenue Growth | ★ 9.61 | 7.98 |
| 52 Week Low | $49.44 | $62.00 |
| 52 Week High | $67.50 | $127.56 |
| Indicator | CBU | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 27.36 | 48.01 |
| Support Level | $56.69 | $83.08 |
| Resistance Level | $58.98 | $87.54 |
| Average True Range (ATR) | 1.62 | 2.57 |
| MACD | -0.66 | -0.32 |
| Stochastic Oscillator | 10.96 | 31.50 |
Community Financial System Inc is a diversified financial services company providing a broad array of banking and other financial services to retail, commercial, institutional and governmental customers. The Company also offers comprehensive financial planning, trust administration and wealth management services through its Community Bank Wealth Management operating unit. It has four reportable operating business segments: Banking and Corporate, Employee Benefit Services, Insurance Services and Wealth Management Services.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.